World Antimalarial Resistance Network (WARN) II: In vitro antimalarial drug susceptibility
Open Access
- 6 September 2007
- journal article
- Published by Springer Science and Business Media LLC in Malaria Journal
- Vol. 6 (1), 120-8
- https://doi.org/10.1186/1475-2875-6-120
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Comparison of a SYBR Green I-Based Assay with a Histidine-Rich Protein II Enzyme-Linked Immunosorbent Assay for In Vitro Antimalarial Drug Efficacy Testing and Application to Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2007
- Amodiaquine and Artemether-Lumefantrine Select Distinct Alleles of the Plasmodium falciparum mdr1 Gene in Tanzanian Children Treated for Uncomplicated MalariaAntimicrobial Agents and Chemotherapy, 2007
- Rapid Dissemination of Plasmodium falciparum Drug Resistance Despite Strictly Controlled Antimalarial UsePLOS ONE, 2007
- Genome variation and evolution of the malaria parasite Plasmodium falciparumNature Genetics, 2006
- Return of Chloroquine Antimalarial Efficacy in MalawiNew England Journal of Medicine, 2006
- Assessment of the Drug Susceptibility of Plasmodium falciparum Clinical Isolates from Africa by Using a Plasmodium Lactate Dehydrogenase Immunodetection Assay and an Inhibitory Maximum Effect Model for Precise Measurement of the 50-Percent Inhibitory ConcentrationAntimicrobial Agents and Chemotherapy, 2006
- Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6The Lancet, 2005
- Excess Polymorphisms in Genes for Membrane Proteins in Plasmodium falciparumScience, 2002
- Genome sequence of the human malaria parasite Plasmodium falciparumNature, 2002
- Chloroquine‐Resistant MalariaThe Journal of Infectious Diseases, 2001